A comparison of diagnostic and management pathways for patients with nung neuroendocrine tumors in ENETS Centres of Excellence vs non-accredited centres in the UK: Results from the... by Talbot, D, Ferguson, S, Mansoor, W

The incidence, diagnostic pathway and management of pulmonary carcinoid tumours in the UK: results from the National Lung NET pathway (‘LEAP’) Project by Ferguson, S, Mansoor, W, Talbot, D

Diagnostic and management pathways for pulmonary carcinoid tumours in the United Kingdom: Results from the National Lung Neuroendocrine Tumour Pathway Project by Mansoor, W, Ferguson, S, Ross, V, Talbot, D

Phase-3 randomized trial of everolimus (RAD001) vs. placebo in advanced pancreatic NET (RADIANT-3) by Chambers, J, Reed, N, Mansoor, W, Ross, P, Grossman, A

Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues by Wolin EM, Jarzab B, Eriksson B, Walter T, Toumpanakis C, Morse MA, Tomassetti P, Weber MM, Fogelman DR, Ramage J, Poon D, Gadbaw B, Li J, Pasieka JL, Mahamat A, Swahn F, Newell-Price J, Mansoor W, Öberg K

Get full text

Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial. by Dutton, S, Ferry, D, Blazeby, J, Abbas, H, Dahle-Smith, A, Mansoor, W, Thompson, J, Harrison, M, Chatterjee, A, Falk, S, Garcia-Alonso, A, Fyfe, D, Hubner, R, Gamble, T, Peachey, L, Davoudianfar, M, Pearson, S, Julier, P, Jankowski, J, Kerr, R, Petty, R

Patient-reported outcomes from a phase HI multicenter, randomized, double-blind, placebo-controlled trial of gefitinib versus placebo in esophageal cancer progressing alter chemoth... by Dutton, S, Blazeby, J, Petty, R, Mansoor, W, Thompson, J, Harrison, M, Abbas, H, Dahle-Smith, A, Chatterjee, A, Falk, S, Garcia-Alonso, A, Fyfe, D, Hubner, R, Gamble, T, Peachey, L, Harvey, C, Julier, P, Jankowski, J, Midgley, R, Ferry, DR, Grp, C

Gefitinib and EGFR gene copy number aberrations in esophageal cancer by Petty, RD, Dahle-Smith, A, Stevenson, DAJ, Osborne, A, Massie, D, Clark, C, Murray, GI, Dutton, SJ, Roberts, C, Chong, IY, Mansoor, W, Thompson, J, Harrison, M, Chatterjee, A, Falk, SJ, Elyan, S, Garcia-Alonso, A, Fyfe, DW, Wadsley, J, Chau, I, Ferry, DR, Miedzybrodzka, Z